Abstract
No public abstract is available from the verified source records.
Rachel P. Rosovsky, Stavros V. Konstantinides, Ido Weinberg, Suhail Y. Dohad, Zachary Rosol, Jakub Stępniewski, John M. Moriarty, Sahil A. Parikh, Andrew Holden, Richard N. Channick, Braedon McDonald, Khanjan H. Nagarsheth, Yuri Matusov, Robert A. Lookstein, Ahmed AlBadri, Mohamed Almahmoud, Sameer Arora, Bulent Arslan, Steve Attanasio, Keith Benzuly, Vivian Bishay, Paul Boiteau, Paul Boucher, Brendan Buckley, Michael Campbell, Chad Christopherson, Yashasvi Chugh, Fareed Moses Collado, Frank Corrigan, Michael Cuttica, Shani Dahan, Laura Davidson, Alex Davidovich, David Dexter, Mihaela-Ioana Dregoesc, Tammer El-Aini, Mahir Elder, Fakhir Elmasri, Rukshan Fernando, Aaron Fischman, James Flaherty, Brian Freeze, Oren Friedman, Jennifer Fung, Siddharth Gandhi, Kirema Garcia-Reyes, M. Kurt Gordon, Paul Guichard, Scott Hamilton, Frank Hao, Eric Herget, Yasin Hussain, Elias Iliadis, Frank Italiano, Natalia Jaworska, Kamil Jonas, Kevin Jones, Minhaj Khaja, Hussein Kiliddar, Grzegorz Kopec, Andreas Kramer, Holger Kuehne, Gautam Kumar, Matthew Langston, Brian Lawler, Marysa Leya, Kevin Liu, Wojciech Magon, Aziz Marzoug, Alan Matsumoto, Michael McDaniel, Shay McGuinness, Stephen Merrilees, Bushra Mina, Sanjay Misra, Peter Monteleone, Nicolas Mouawad, Ruben Mylvaganam, Jean Panneton, Ken Parhar, Jong Park, Gaurav Parmar, Jonathan Passeri, Marloe Prince, Mona Ranade, Animesh Rathore, Lisa Rauschert, Rehan Riaz, Willie Robinson, Rajesh Sachdeva, Robert Salazar, Daniel Schimmel, Jeffrey Schussler, Matthew Sebastian, Janet Shapiro, Abdul Sheikh, Dan Shilo, Alexander Sidor, Geoffrey Southmayd, Jonathan Steinberger, Lucas Struycken, Ranya Sweis, Jordan Tasse, Manoj Thangam, Benjamin Tritle, Michael Troy, Ulku Turba, Jenanan Vairavamurthy, Ilaria Vittoria De Martini, Marcin Waligora, Lawrence Whitney, Jason Wong, Gregory Woodhead
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Randomized controlled trial of mechanical thrombectomy with anticoagulation versus anticoagulation alone for acute intermediate-high risk pulmonary embolism: primary outcomes from the STORM-PE trial
10.1161/circulationaha.125.077232 · 2025
Health-related quality of life and mortality in patients with pulmonary embolism: a prospective cohort study in seven European countries
10.1007/s11136-019-02175-z · 2019
Functional capacity and dyspnea during follow-up after acute pulmonary embolism
10.1016/j.jtha.2023.08.024 · 2024
Quality of life in long-term survivors of acute pulmonary embolism
10.1378/chest.09-2482 · 2010
Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism
10.1161/circulationaha.113.005544 · 2014
Clinical, functional, and quality-of-life outcomes after computer assisted vacuum thrombectomy for pulmonary embolism: interim analysis of the STRIKE-PE study
10.1016/j.jvir.2024.04.028 · 2024
Acute outcomes for the full US cohort of the FLASH mechanical thrombectomy registry in pulmonary embolism
10.4244/eij-d-22-00732 · 2023
Longer-term outcomes following mechanical thrombectomy for intermediate- and high-risk pulmonary embolism: 6-month FLASH registry results
2023
One-year echocardiographic, functional, and quality of life outcomes after ultrasound-facilitated catheter-based fibrinolysis for pulmonary embolism
10.1161/circinterventions.120.009012 · 2020
10.1016/j.ahj.2025.03.018
10.1016/j.ahj.2025.03.018 · 2025
ATS statement: guidelines for the six-minute walk test
10.1164/ajrccm.166.1.at1102 · 2002
Reference equations for the six-minute walk in healthy adults
10.1164/ajrccm.158.5.9710086 · 1998
Unresolved referenced work
1979
Agreement of the modified medical research council and New York Heart Association scales for assessing the impact of self-rated breathlessness in cardiopulmonary disease
10.1183/23120541.00460-2021 · 2022
Measuring functional limitations after venous thromboembolism: optimization of the Post-VTE Functional Status (PVFS) Scale
10.1016/j.thromres.2020.03.020 · 2020
Functional limitations 3 and 12 months after venous thromboembolism: a cohort study
10.1016/j.rpth.2024.102464 · 2024
Quality of life after pulmonary embolism: the development of the PEmb-QoL questionnaire
10.1111/j.1538-7836.2009.03341.x · 2009
Unresolved referenced work
2015
Multiple imputation using chained equations: issues and guidance for practice
10.1002/sim.4067 · 2011
Baseline exercise tolerance and perceived dyspnea to identify the ideal candidate to pulmonary rehabilitation: a risk chart in COPD patients
10.2147/copd.s223038 · 2019
Determining the minimal clinically important difference for the PEmbQoL questionnaire, a measure of pulmonary embolism-specific quality of life
10.1111/jth.14302 · 2018
The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference
10.1136/thoraxjnl-2015-207782 · 2016
6 min walk test is a strong independent predictor of death in outpatients with heart failure
10.1002/ehf2.12900 · 2020
The 6MWT as a prognostic tool in pulmonary arterial hypertension: results from the COMPERA registry
10.1007/s00392-018-1207-5 · 2018
Health-related quality of life after pulmonary embolism: a cross-sectional study
10.1136/bmjopen-2016-013086 · 2016
10.1093/eurheartj/ehv317
10.1093/eurheartj/ehv317 · 2016
Persistent right ventricular dysfunction, functional capacity limitation, exercise intolerance, and quality of life impairment following pulmonary embolism: systematic review with meta-analysis
10.1177/1358863x16670250 · 2017
Large-bore mechanical thrombectomy versus catheter-directed thrombolysis in the management of intermediate-risk pulmonary embolism: primary results of the PEERLESS randomized controlled trial
10.1161/circulationaha.124.072364 · 2025
Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial
10.1111/jth.12521 · 2014
Persistent dyspnea complaints at long-term follow-up after an episode of acute pulmonary embolism: results of a questionnaire
10.1016/j.ejim.2008.02.006 · 2008
Fibrinolysis for patients with intermediate-risk pulmonary embolism
10.1056/nejmoa1302097 · 2014
Echocardiographic and functional cardiopulmonary problems 6 months after first-time pulmonary embolism in previously healthy patients
10.1093/eurheartj/ehm295 · 2007
Functional and exercise limitations after a first episode of pulmonary embolism: results of the ELOPE prospective cohort study
10.1016/j.chest.2016.11.030 · 2017
Quality of life 3 and 12 months following acute pulmonary embolism: analysis from a prospective multicenter cohort study
10.1016/j.chest.2021.01.071 · 2021
Burden and long-term impact of pulmonary embolism on health-related quality of life: a matched cohort study
10.1093/eurjpc/zwaf307 · 2025
Peerless II: a randomized controlled trial of large-bore thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism
2024
Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: rationale and design of the HI-PEITHO study
10.1016/j.ahj.2022.05.011 · 2022
Rationale and design of the PE-TRACT trial: a multicenter randomized trial to evaluate catheter-directed therapy for the treatment of intermediate-risk pulmonary embolism
10.1016/j.ahj.2024.11.016 · 2025
Residual pulmonary thromboemboli after acute pulmonary embolism
10.1016/j.ejim.2011.08.018 · 2012
The post-PE syndrome: a new concept for chronic complications of pulmonary embolism
10.1016/j.blre.2014.07.003 · 2014
No additional external references are available.